+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-10-01Number of Pages: 113

PAP and Paracetamol Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2022

The global para-aminophenol (PAP) and paracetamol market has been growing due to the increasing cases of chronic diseases and conditions that need pain management solutions on a regular basis. About 80% of PAP produced worldwide is used for making paracetamol. Thus, the increasing consumption of the latter is directly impacting the growth of PAP market. Additionally, the growing awareness about the pain management solutions offered by paracetamol, which is essentially an effective analgesic, is a key factor boosting paracetamol consumption across the globe. The application of PAP (para-aminophenol) in several other areas such as for making dyes, rubber antioxidants, photo-developing agents, anti-ager, and other chemicals is also propelling the global market. 

Transparency Market Research predicts that the opportunity in the global paracetamol market is expected to be worth US$1,049.7 mn by 2022 as against to US$900.2 mn in 2014. Meanwhile, the para-aminophenol (PAP) market, will reach US$709.2 mn by 2022 from US$452.7 mn in 2014. The emergence of India and China as leading chemical producers have also presented a score of opportunities to the overall market as PAP is expected to find increasing application in industries such as agro-chemicals, pharmaceuticals, and dyes amongst others. Players are also expected to tap into supportive infrastructural setup offered by emerging economies of Asia Pacific to increase and diversify their manufacturing capabilities.

North America to Account for 40% of Global Market by Volume by 2022

North America leads the global market, poised to account for 40% of the total market share in terms of volume by 2022. The region’s standing will be the result of a growing number of PAP manufacturers and a strong presence of state-of-art manufacturing units. The persistent efforts made to upgrade from chemical production to specialty chemical production in the region have also boosted the market in the recent past. Additionally, attempts to adhere to environmental regulations pertaining to manufacturing processes are also propelling the PAP market in North America.

Asia Pacific Market Flourishes with Advantage of Reduced Manufacturing Costs

TMR estimates that the Asia Pacific PAP market will exhibit a steady CAGR of 3.9% between 2014 and 2022, while the paracetamol market will rise at a CAGR of 1.9% during the same forecast period. Asia Pacific is expected to present abundant opportunities to the PAP and paracetamol market due to low labor costs, affordable research and development costs, a larger base of manpower, supportive infrastructure, and increasing trade volume due to an exponentially rising consumer base. These are the common denominators driving the consumption and production of PAP and paracetamol in emerging economies of China and India.

An influx of investments in chemicals and pharmaceuticals industry has built the perfect framework for the consumption of PAP in various agro-chemicals and dyes along with a range of pharmaceutical compositions. All of these aspects have resulted in reduced costs of final products in comparison to products manufactured in North America and other European regions. Thus, consumers are preferring Asian products over others, while manufacturers are shifting bases to indulge in cost-benefits offered by countries in Asia Pacific. Citing these reasons, analysts predict that Asia Pacific will emerge as a significant regional segment during the forecast period.

Some of the leading players operating in the global PAP and paracetamol market are Mallinckrodt plc, Granules India, Angene International Limited, Haihang Industry Co., Ltd., Jinan Haohua Industry Co., Ltd., Parchem Fine & Specialty Chemicals, and Kemcolour International. Companies will strengthen their distribution channels to reach out to a wider audience to maintain their leadership in the overall market.


Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
      1.2.1 Market Segmentation: PAP and Paracetamol
1.3 Research Methodology
      1.3.1 Secondary Research
      1.3.2 Primary Research
1.4 Factors Considered During Market Estimations

Chapter 2 Executive Summary
2.1 Introduction
2.2 Paracetamol
      2.2.1 Market Snapshot: Global Paracetamol Market (2014 and 2022)
      2.2.2 Comparative Analysis: Global Paracetamol Market (Consumption) Volume, by Geography, 2014 and 2022 (Value %)
2.3 P-aminophenol (PAP)
      2.3.1 Market Snapshot: Global PAP Market (2014 and 2022)
      2.3.2 Comparative Analysis: Global PAP Market Volume, by Geography, 2014 and 2022 (Value %)
2.4 Market Attractiveness Analysis: Global PAP and Paracetamol Market, 2014

Chapter 3 P-aminophenol (PAP) Market Overview
3.1 Market Dynamics
      3.1.1 Drivers
             3.1.1.1 Growth in end-use sector could propel demand for para-aminophenol (PAP)
             3.1.1.2 Rapid emergence of China and India as the largest chemical producers in Asia
             3.1.1.3 Development of exclusive production techniques and focus on inorganic growth
      3.1.2 Restraints
             3.1.2.1 Rising focus on green chemistry, solvent-free synthesis of PAP
      3.1.3 Opportunities
             3.1.3.1 Promising emerging economies
             3.1.3.2 Focus on backward and forward integration
             3.1.3.3 Forming alliances with international majors
3.2 Porter’s Five Forces Analysis: Global PAP Market
      3.2.1 Bargaining Power of Suppliers
      3.2.2 Bargaining Power of Buyers
      3.2.3 Threat of Substitutes
      3.2.4 Threat of New Entrants
      3.2.5 Competitive Rivalry
3.3 Event Impact Analysis: Global  PAP Market
3.4 Value Chain Analysis: PAP Market
3.5 List of PAP Producers
3.6 List of PAP Plants Closures

Chapter 4 Global PAP Market, by Geography
4.1 Introduction
      4.1.1 Global PAP Market Revenue, by Geography, 2012–2022 (USD Million)
      4.1.2 Global PAP Consumption Volume, by Geography, 2012–2022 (Tonnes)
      4.1.3 Global PAP Demand Volume, by Geography, 2012–2022 (Tonnes)
      4.1.4 Global PAP Production Volume, by Geography, 2012–2022 (Tonnes)
4.2 North America
      4.2.1 North America PAP Market Revenue, 2012–2022 (USD Million)
      4.2.2 North America PAP Production Volume, 2012–2022 (Tonnes)
      4.2.3 North America PAP Consumption Volume, 2012–2022 (Tonnes)
      4.2.4 North America PAP Demand Volume, 2012–2022 (Tonnes)
4.3 Europe
      4.3.1 Europe PAP Market Revenue, 2012–2022 (USD Million)
      4.3.2 Europe PAP Production Volume, 2012-2010
      4.3.3 Europe PAP Consumption Volume, 2012–2022 (Tonnes)
      4.3.4 Europe PAP Demand Volume, 2012–2022 (Tonnes)
4.4 Asia Pacific
      4.4.1 Asia Pacific PAP Market Revenue, 2012–2022 (USD Million)
      4.4.2 Asia Pacific PAP Production Volume, 2012–2022 (Tonnes)
      4.4.3 Asia Pacific PAP Consumption Volume, 2012–2022 (Tonnes)
      4.4.4 Asia Pacific PAP Demand Volume, 2012–2022 (Tonnes)
4.5 Latin America
      4.5.1 Latin America PAP Market Revenue, 2012–2022 (USD Million)
      4.5.2 Latin America PAP Consumption Volume, 2012–2022 (Tonnes)
      4.5.3 Latin America PAP Production Volume, 2012-2022 (Tonnes)
      4.5.4 Latin America PAP Demand Volume, 2012–2022 (Tonnes)
4.6 Middle East
      4.6.1 Middle East PAP Market Revenue, 2012–2022 (USD Million)
      4.6.2 Middle East PAP Consumption Volume, 2012–2022 (Tonnes)
      4.6.3 Middle East PAP Demand Volume, 2012–2022 (Tonnes)
4.7 Rest of the World (RoW)
      4.7.1 Rest of the World PAP Market Revenue, 2012–2022 (USD Million)
      4.7.2 Rest of the World PAP Consumption Volume, 2012–2022 (Tonnes)
      4.7.3 Rest of the World PAP Demand Volume, 2012–2022 (Tonnes)

Chapter 5 Paracetamol (Acetaminophen/APAP) Market Overview
5.1 Overview
5.2 Market Drivers
      5.2.1 Rise in pain-related incidences
      5.2.2 Advantages over other analgesics
5.3 Restraints
      5.3.1 Several contraindications and adverse effects
      5.3.2 High competition among pain relievers
5.4 Opportunities
      5.4.1 Product differentiation through technological innovations, combination products, new formulations, and indications
5.5 Porter’s Five Forces Analysis: Global Paracetamol Market
      5.5.1 Bargaining Power of Suppliers
      5.5.2 Bargaining Power of Buyers
      5.5.3 Threat of New Entrants
      5.5.4 Threat of Substitutes
      5.5.5 Competitive Rivalry
5.6 Event Impact Analysis: Global Paracetamol Market
5.7 Value Chain Analysis: Paracetamol Market
5.8 List of Paracetamol Producers
5.9 List of Paracetamol Plant Closures

Chapter 6 Global Paracetamol (Acetaminophen, APAP) Market, by Geography
6.1 Introduction
      6.1.1 Global Paracetamol Market Revenue, by Geography, 2012–2022 (USD Million)
      6.1.2 Global Paracetamol Consumption Volume, by Geography, 2012–2022 (Tonnes)
      6.1.3 Global Paracetamol Demand Volume, by Geography, 2012–2022 (Tonnes)
      6.1.4 Global Paracetamol Production Volume, by Geography, 2012–2022     (Tonnes)
6.2 North America
      6.2.1 Production, Trade, and Consumption Analysis
             6.2.1.1 North America Paracetamol (APAP) Market Revenue, 2012–2022 (USD Million)
             6.2.1.2 North America Paracetamol (APAP) Production Volume, 2012–2022 (Tonnes)
             6.2.1.3 North America Paracetamol (APAP) Consumption Volume, 2012–2022 (Tonnes)
      6.2.2 Demand and Supply Analysis
             6.2.2.1 North America Paracetamol (APAP) Demand Volume, 2012–2022 (Tonnes)
6.3 Europe
      6.3.1 Production, Trade, and Consumption Analysis
             6.3.1.1 Europe Paracetamol (APAP) Market Revenue, 2012–2022 (USD Million)
             6.3.1.2 Europe Paracetamol (APAP) Production Volume, 2012–2022 (Tonnes)
             6.3.1.3 Europe Paracetamol (APAP) Consumption Volume, 2012–2022 (Tonnes)
      6.3.2 Demand and Supply Analysis
             6.3.2.1 Europe Paracetamol (APAP) Demand Volume, 2012–2022 (Tonnes)
6.4 Asia Pacific
      6.4.1 Production, Trade, and Consumption Analysis
             6.4.1.1 Asia Pacific Paracetamol (APAP) Market Revenue, 2012–2022 (USD Million)
             6.4.1.2 Asia Pacific Paracetamol (APAP) Production Volume, 2012–2022 (Tonnes)
             6.4.1.3 Asia Pacific Paracetamol (APAP) Consumption Volume, 2012–2022 (Tonnes)
      6.4.2 Demand and Supply Analysis
             6.4.2.1 Asia Pacific Paracetamol (APAP) Demand Volume, 2012–2022 (Tonnes)
6.5 Latin America
      6.5.1 Production, Trade, and Consumption Analysis
             6.5.1.1 Latin America Paracetamol (APAP) Market Revenue, 2012–2022 (USD Million)
             6.5.1.2 Latin America Paracetamol (APAP) Production Volume, 2012–2022 (Tonnes)
             6.5.1.3 Latin America Paracetamol (APAP) Consumption Volume, 2012–2022 (Tonnes)
      6.5.2 Demand and Supply Analysis
             6.5.2.1 Latin America Paracetamol (APAP) Demand Volume, 2012–2022 (Tonnes)
6.6 Middle East
      6.6.1 Production, Trade, and Consumption Analysis
             6.6.1.1 Middle East Paracetamol (APAP) Market Revenue, 2012–2022 (USD Million)
             6.6.1.2 Middle East Paracetamol (APAP) Consumption Volume, 2012–2022 (Tonnes)
      6.6.2 Demand and Supply Analysis
             6.6.2.1 Middle East Paracetamol (APAP) Demand Volume, 2012–2022 (Tonnes)
6.7 Rest of the World (RoW)
      6.7.1 Production, Trade, and Consumption Analysis
             6.7.1.1 Rest of the World Paracetamol (APAP) Market Revenue, 2012–2022 (USD Million)
             6.7.1.2 Rest of the World Paracetamol (APAP) Consumption Volume, 2012–2022 (Tonnes)
      6.7.2 Demand and Supply Analysis
             6.7.2.1 Rest of the World Paracetamol (APAP) Demand Volume, 2012–2022 (Tonnes)

Chapter 7 Recommendations
7.1 Recommendations
      7.1.1 Pharmaceutical collaborations
      7.1.2 Focus on process improvements to remain competitive
      7.1.3 Cost containment/optimization measures

Chapter 8 Company Profiles
8.1 Angene International Limited
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Product Portfolio
      8.1.4 Business Strategies
      8.1.5 Recent Developments
8.2 BOC Sciences
      8.2.1 Company Overview
      8.2.2 Financial Overview
      8.2.3 Business Strategies
      8.2.4 Recent Developments
8.3 Granules India Limited
      8.3.1 Company Overview
      8.3.2 Financial Overview
      8.3.3 Business Strategies
      8.3.4 Recent Development
8.4 Haihang Industry Co., Ltd.
      8.4.1 Company Overview
      8.4.2 Financial Overview
      8.4.3 Business Strategies
      8.4.4 Recent Developments
8.5 Jinan Haohua Industry Co., Ltd.
      8.5.1 Company Overview
      8.5.2 Financial Overview
      8.5.3 Business Strategies
      8.5.4 Recent Developments
8.6 Mallinckrodt Pharmaceuticals
      8.6.1 Company Overview
      8.6.2 Financial Overview
      8.6.3 Product Portfolio
      8.6.4 Business Strategies
      8.6.5 Recent Developments
8.7 ORGANICA Feinchemie GmbH Wolfen
      8.7.1 Company Overview
      8.7.2 Financial Overview
      8.7.3 Business Strategies
      8.7.4 Recent Developments
8.8 WuXi PharmaTech
      8.8.1 Company Overview
      8.8.2 Financial Overview
      8.8.3 Product Portfolio
      8.8.4 Business Strategies
      8.8.5 Recent Developments

List of Figures

FIG. 1 Market Segmentation: PAP and Paracetamol
FIG. 2 Comparative Analysis: Global Paracetamol Market (Consumption) Volume, by Geography, 2014 and 2022 (Value %)
FIG. 3 Comparative Analysis: Global PAP Market (Consumption) Volume, by Geography, 2014 and 2022 (Value %)
FIG. 4 Market Attractiveness Analysis: Global PAP and Paracetamol Market, 2014
FIG. 5 Porter’s Five Forces Analysis: Global PAP Market
FIG. 6 Value Chain Analysis: PAP Market
FIG. 7 North America PAP Market Revenue, 2012–2022 (USD Million)
FIG. 8 North America PAP Production Volume, 2012-2022 (Tonnes)
FIG. 9 North America PAP Consumption Volume, 2012–2022 (Tonnes)
FIG. 10 North America PAP Demand Volume, 2012–2022 (Tonnes)
FIG. 11 Europe PAP Market Revenue, 2012–2022 (USD Million)
FIG. 12 Europe PAP Production Volume, 2012–2010 (Tonnes)
FIG. 13 Europe PAP Consumption Volume, 2012–2022 (Tonnes)
FIG. 14 Europe PAP Demand Volume, 2012–2022 (Tonnes)
FIG. 15 Asia Pacific PAP Market Revenue, 2012–2022 (USD Million)
FIG. 16 Asia Pacific PAP Production Volume, 2012–2022 (Tonnes)
FIG. 17 Asia Pacific PAP Consumption Volume, 2012-2022 (Tonnes)
FIG. 18 Asia Pacific PAP Demand Volume, 2012–2022 (Tonnes)
FIG. 19 Latin America PAP Market Revenue, 2012–2022 (USD Million)
FIG. 20 Latin America PAP Consumption Volume, 2012–2022 (Tonnes)
FIG. 21 Latin America PAP Production Volume, 2012–2022 (Tonnes)
FIG. 22 Latin America PAP Demand Volume, 2012-2022 (Tonnes)
FIG. 23 Middle East PAP Market Revenue, 2012–2022 (USD Million)
FIG. 24 Middle East PAP Consumption Volume, 2012–2022 (Tonnes)
FIG. 25 Middle East PAP Demand Volume, 2012–2022 (Tonnes)
FIG. 26 Rest of the World PAP Market Revenue, 2012–2022 (USD Million)
FIG. 27 Rest of the World PAP Consumption Volume, 2012-2022 (Tonnes)
FIG. 28 Rest of the World PAP Demand Volume, 2012–2022 (Tonnes)
FIG. 29 Porter’s Five Forces Analysis: Global Paracetamol Market
FIG. 30 Value Chain Analysis: Paracetamol Market
FIG. 31 North America Paracetamol (APAP) Market Revenue, 2012–2022 (USD Million)
FIG. 32 North America Paracetamol (APAP) Production Volume, 2012–2022 (Tonnes)
FIG. 33 North America Paracetamol (APAP) Consumption Volume, 2012–2022 (Tonnes)
FIG. 34 North America Paracetamol (APAP) Demand Volume, 2012–2022 (Tonnes)
FIG. 35 Europe Paracetamol (APAP) Market Revenue, 2012–2022 (USD Million)
FIG. 36 Europe Paracetamol (APAP) Production Volume, 2012–2022 (Tonnes)
FIG. 37 Europe Paracetamol (APAP) Consumption Volume, 2012–2022 (Tonnes)
FIG. 38 Europe Paracetamol (APAP) Demand Volume, 2012–2022 (Tonnes)
FIG. 39 Asia Pacific Paracetamol (APAP) Market Revenue, 2012–2022 (USD Million)
FIG. 40 Asia Pacific Paracetamol (APAP) Production Volume, 2012–2022 (Tonnes)
FIG. 41 Asia Pacific Paracetamol (APAP) Consumption Volume, 2012–2022 (Tonnes)
FIG. 42 Asia Pacific Paracetamol (APAP) Demand Volume, 2012–2022 (Tonnes)
FIG. 43 Latin America Paracetamol (APAP) Market Revenue, 2012–2022 (USD Million)
FIG. 44 Latin America Paracetamol (APAP) Production Volume, 2012–2022 (Tonnes)
FIG. 45 Latin America Paracetamol (APAP) Consumption Volume, 2012–2022 (Tonnes)
FIG. 46 Latin America Paracetamol (APAP) Demand Volume, 2012–2022 (Tonnes)
FIG. 47 Middle East Paracetamol (APAP) Market Revenue, 2012–2022 (USD Million)
FIG. 48 Middle East Paracetamol (APAP) Consumption Volume, 2012–2022 (Tonnes)
FIG. 49 Middle East Paracetamol (APAP) Demand Volume, 2012–2022 (Tonnes)
FIG. 50 Rest of the World Paracetamol (APAP) Market Revenue, 2012–2022 (USD Million)
FIG. 51 Rest of the World Paracetamol (APAP) Consumption Volume, 2012–2022 (Tonnes)
FIG. 52 Rest of the World Paracetamol (APAP) Demand Volume, 2012–2022 (Tonnes)
FIG. 53 Granules India Limited: Annual Revenue, 2012 – 2014 (USD Million)
FIG. 54 Annual Revenue: Mallinckrodt Pharmaceuticals (By Segment), 2012 – 2014 (USD Million)
FIG. 55 WuXi PharmaTech (Cayman), Inc.: Annual Sales Revenue, 2011 – 2013 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Paracetamol Market (2014 and 2022)
TABLE 2 Market Snapshot: Global PAP Market (2014 and 2022)
TABLE 3 Event Impact Analysis: Global PAP Market
TABLE 4 Global PAP Market Revenue, by Geography, 2012–2022 (USD Million)
TABLE 5 Global PAP Consumption Volume, by Geography, 2012–2022 (Tonnes)
TABLE 6 Global PAP Demand Volume, by Geography, 2012–2022 (Tonnes)
TABLE 7 Global PAP Production Volume, by Geography, 2012–2022 (Tonnes)
TABLE 8 Global Paracetamol Market Revenue, by Geography, 2012–2022 (USD Million)
TABLE 9 Global Paracetamol Consumption Volume, by Geography, 2012–2022 (Tonnes)
TABLE 10 Global Paracetamol Demand Volume, by Geography, 2012–2022 (Tonnes)
TABLE 11 Global Paracetamol Production Volume, by Geography, 2012–2022 (Tonnes)

Paracetamol, also known as acetaminophen, is a pain reliever and an antipyretic. The drug is administered either alone or in combination, or as an alternative to aspirin due to comparatively fewer side effects. Para-aminophenol (PAP) is a final intermediate in the industrial synthesis of paracetamol and is used in the manufacture of products having various application in different sectors such as pharmaceuticals, dye industries, and fine chemicals. The report on the global paracetamol and para-aminophenol market studies the current and future prospects of the market with respect to demand, consumption, and production. The report comprises an elaborate executive summary, which includes a market snapshot that provides overall information of various segments and sub-segments. This section also provides the overall information and data analysis of the global paracetamol and para-aminophenol market.

The report showcases market overview section individually for PAP and paracetamol. This section  of the report includes qualitative analysis of the paracetamol and para-aminophenol market considering the factors determining the market dynamics such as drivers, restraints, and opportunities along with Porter’s Five Forces Analysis and market attractiveness analysis. In addition, various analyses such as value chain analysis and market attractiveness analysis by geography and competitive landscape by key players has been provided. Value chain analysis includes the study of major steps involved in the production and distribution of paracetamol and para-aminophenol. The market attractiveness analysis has been provided in order to explain the intensity of competition in the market in different geographies. The competitive scenario between different market players is evaluated through market share analysis in the competitive landscape section of the report.

In order to understand the global scenario of the paracetamol and para-aminophenol industry, the report also includes a table demonstrating the existing manufacturing plants, and the plants closed for both paracetamol as well as para-aminophenol. All these factors would help the market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market. Geographically, the paracetamol and para-aminophenol market has been segmented into six regions: North America, Europe, Asia-Pacific, Latin America, the Middle East, and Rest of the World (RoW). The report includes historical as well as forecast data on production, trade, and consumption analysis and supply and demand of paracetamol and para-aminophenol in each region, wherein 2012 and 2013 form the historical years.

The recommendations section include in the report would assist the existing players to expand their market shares. The report also profiles major players in the paracetamol and para-aminophenol market on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Angene International Limited, BOC Sciences, Granules India, Haihang Industry Co., Ltd., Jinan Haohua Industry Co., Ltd., Kemcolour International, Mallinckrodt plc, ORGANICA Feinchemie GmbH Wolfen, Parchem Fine & Specialty Chemicals, Wuxi Feipeng Imp. & Exp. (Group) Co., Limited, and Zhejiang Hisun Chemical Co., Limited.
The global PAP and Paracetamol market is segmented as follows:

Global PAP Market Revenue, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Australia
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Rest of the World

Global Paracetamol Market Revenue, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Australia
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Rest of the World


 
 
Back To Top